Jenscare Scientific Co., Ltd.
Research Jenscare Scientific Co., Ltd. (9877.HK) on Bullrun: market cap HKD 2.84B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker9877.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyHKD
- Market capHKD 2.84B
- Financial periodFY2025
- RevenueCNY 90.59M
- Net income-CNY 271.23M
- Free cash flow-CNY 80.08M
- Gross margin91.1%
Valuation Snapshot
latest market cap is HKD 2.84B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 90.59M | -CNY 271.23M | -CNY 80.08M | 91.1% | n/a | CNY 507.41M | CNY 47.36M | CNY 789.41M |
| FY2024 | CNY 0 | -CNY 177.51M | -CNY 289.24M | n/a | -0.43 | CNY 605.99M | CNY 64.42M | CNY 931.76M |
| FY2023 | CNY 0 | -CNY 371.74M | -CNY 301.07M | n/a | -0.89 | CNY 927.83M | CNY 44.08M | CNY 1.23B |
| FY2022 | CNY 0 | -CNY 439.31M | -CNY 208.03M | n/a | -1.2 | CNY 727.36M | CNY 3.87M | CNY 1.37B |
| FY2021 | n/a | n/a | n/a | n/a | -1.2 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 2.84B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Jenscare Scientific Co., Ltd.
Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of interventional products for the treatment of structural heart diseases in the People's Republic of China. It offers LuX-Valve and LuX-Valve Plus, a transcatheter tricuspid valve replacement (TTVR) product for the treatment of severe tricuspid regurgitation and high surgical risk; Ken-Valve, a TRVR system for the treatment of severe aortic regurgitation or combined with aortic stenosis.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Jenscare Scientific Co., Ltd.'s market cap?
Jenscare Scientific Co., Ltd.'s market capitalization is HKD 2.84B.
What does Jenscare Scientific Co., Ltd. do?
Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of interventional products for the treatment of structural heart diseases in the People's Republic of China. It offers LuX-Valve and LuX-Valve Plus, a transcatheter tricuspid valve replacement (TTVR) product for the treatment of severe tricuspid regurgitation and high surgical risk; Ken-Valve, a TRVR system for the treatment of severe aortic regurgitation or combined with aortic stenosis.